# Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting

> **NCT07109375** · — · NOT_YET_RECRUITING · sponsor: **Chiesi Italia** · enrollment: 75 (estimated)

## Conditions studied

- Fabry Disease

## Interventions

- **DRUG:** pegunigalsidase alfa

## Key facts

- **NCT ID:** NCT07109375
- **Lead sponsor:** Chiesi Italia
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07109375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07109375, "Observational Study on Long-term Use of Pegunigalsidase Alfa in Fabry Patients in a Real-world Setting". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07109375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*